Larry Noracle Partners Lp F... Net Worth

The estimated Net Worth of Larry Noracle Partners Lp F... is at least $5.16 Million dollars as of 5 June 2020. Larry F owns over 200,243 units of Motus GI Inc stock worth over $20,305 and over the last 6 years Larry sold MOTS stock worth over $5,136,430.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Larry F MOTS stock SEC Form 4 insiders trading

Larry has made over 11 trades of the Motus GI Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently Larry sold 59,115 units of MOTS stock worth $112,319 on 26 January 2021.

The largest trade Larry's ever made was selling 5,173,250 units of Motus GI Inc stock on 8 June 2020 worth over $2,845,288. On average, Larry trades about 607,651 units every 76 days since 2018. As of 5 June 2020 Larry still owns at least 655,000 units of Motus GI Inc stock.

You can see the complete history of Larry F stock trades at the bottom of the page.

What's Larry F's mailing address?

Larry's mailing address filed with the SEC is 3, 200 Greenwich Ave, Greenwich, CT 06830, USA.

Insiders trading at Motus GI Inc

Over the last 7 years, insiders at Motus GI Inc have traded over $2,638,819 worth of Motus GI Inc stock and bought 3,952,265 units worth $13,986,863 . The most active insiders traders include Advisors Llcperceptive Life..., Larry Noracle Partners Lp F..., and David P Hochman. On average, Motus GI Inc executives and independent directors trade stock every 33 days with the average trade being worth of $4,105. The most recent stock trade was executed by Andrew Lawrence Taylor on 19 November 2021, trading 2,000 units of MOTS stock currently worth $1,020.

What does Motus GI Inc do?

motus gi holdings, inc. (nasdaq: mots) is a medical technology company based in the u.s., with subsidiaries in the u.s. and israel, dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. the company is focused on the development and commercialization of the pure-vu® system, designed to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. the pure-vu® system is a 510(k) u.s. food and drug administration cleared medical device indicated to help facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. the device integrates with standard colonoscopes to enable cleaning during the procedure while preserving standard procedural workflow and techniques. the pure-vu® system has received ce mark approval in europe.

Complete history of Larry F stock trades at Biolase Inc, Soleno Therapeutics Inc, Vermillion, and Motus GI Inc

Motus GI Inc executives and stock owners

Motus GI Inc executives and other stock owners filed with the SEC include:

• Timothy Moran,
  Chief Executive Officer, Director
• Timothy P. Moran,
  CEO & Director
• Mark Pomeranz,
  President, Chief Operating Officer, Director
• Andrew Taylor,
  Chief Financial Officer
• Mark Pomeranz,
  Pres, COO & Director
• Andrew Lawrence Taylor M.B.A.,
  Chief Financial Officer
• David Hochman,
  Independent Chairman of the Board
• Bob Yedid,
  Managing Director
• Darren Sherman,
  Independent Director
• Gary Pruden,
  Independent Director
• Samuel Nussbaum,
  Independent Director
• Shervin Korangy,
  Independent Director
• Scott C. Aldrich Jr.,
  VP of Marketing & Strategy
• Llc Abv,,
  
• Gary E. Jacobs,
  Director
• Biomedical Ventures Ii, L.P...,
  
• Advisors Llcperceptive Life...,
  
• Larry Noracle Partners Lp F...,
  
• Scott Durbin,
  Director
• Sonja Nelson,
  Director